FIDEL.X
Transfidelity

0
Loading...
Loading...
News
all
press releases

Sentiment

Indicates whether most users posting on a symbol’s stream over the last 24 hours are fearful or greedy.
0
25
50
75
100
Extreme
Fear
Neutral
Greed
Extreme
Fear
Greed
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Message Volume

Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

Participation Ratio

Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score

N/A

1 day ago

Sign Up / Log In

1 week ago

Sign Up / Log In

1 month ago

Sign Up / Log In

3 months ago

Sign Up / Log In

6 months ago

Sign Up / Log In

1 year ago

Sign Up / Log In

AboutNeurodegenerative diseases such as Alzheimer's Disease are devastating conditions that impact millions globally. These diseases are driven by the misfolding and aggregation of proteins, which lead to brain cell death and cognitive decline. To make matters worse, as we age our cells become more error-prone, resulting in more errors during protein printing, causing proteins to clump together and form aggregates. Project Transfidelity aims to solve this by improving the accuracy of protein printing, preventing toxic aggregates from forming. Led by Dr. Dimitri Scherbakov and Dr. Rashid Akbergenov, with over 50 years of combined experience in the lab, we have identified two molecules that may improve the efficiency of protein production, potentially preventing protein aggregates, hypothesized to cause dementia. Despite the significant research funding allocated to neurodegenerative diseases, current therapies continue to treat the symptoms caused by the protein aggregates, with little progress made to stop or reverse disease. We’re trying to go after a potential root cause - rather than trying to clear aggregates once they are there, we aim to prevent them from forming in the first place by reducing the production of faulty proteins. With a clear path towards developing novel intellectual property (IP) and an ever-growing target market, we believe we are poised to make an impact on neurodegenerative disorders and the way we age.Show More
Details
Links
Source
Categories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
September 05, 2025
$594,333.79
$44,613.19
---
September 05, 2025
$613,165.07
$45,710.52
---
September 04, 2025
$620,432.68
$39,702.82
$0.62
September 03, 2025
$615,367.74
$50,626.51
$0.62
September 02, 2025
$0.00
$48,636.90
$0.56
September 01, 2025
$0.00
$50,846.48
$0.58
August 31, 2025
$0.00
$50,846.48
$0.58

Poll

September has historically been the worst month for crypto. Will 2025 break the trend?
Yes, Bitcoin finishes higher
No, Bitcoin drops again
Flat / no big move

Latest FIDEL.X News

View
No FIDEL.X news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.